Combination of transcatheter arterial chemoembolization and CT-guided radiofrenquency ablation in treating advanced hepatocellular carcinoma

Objective To investigate the therapeutic effect of transcatheter arterial chemo-embolization (TACE) combined with CT-guided percutaneous radiofrequency ablation (RFA) in treating advanced primary hepatocellular carcinoma. Methods Eighty-five cases with advanced primary hepatocellular carcinoma were randomly divided into group A and group B. In group A, 43 cases were treated with TACE, and in group B, 42 cases were treated with TACE and RFA. Results The complete necrosis rate of tumor, the recurrence rate, and one-year survival rate were 20 93%, 39.53%, and 79 07%, respectively in group A, and 92.86%?9.53%, and 97.62%, respectively in group B. There were significant statistical differences between the two groups (P value were 0.001, 0.004, and 0 009, respectively). Conclusion The therapeutic effects of TACE combined with CT-guided RFA show better results than that of TACE alone.